{
    "code": "01R00009",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01R00009",
    "time": "2016-02-19 04:06:52",
    "許可證字號": "衛署藥製字第R00009號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/01\/07",
    "註銷理由": "許可證已逾有效期",
    "有效日期": "101\/02\/26",
    "發證日期": "81\/02\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY001R0000903",
    "中文品名": "碘１３１碘化油肝癌注射劑",
    "英文品名": "I-131-LIPIODOL MALIGNANT HEPATOMA INJECTION",
    "適應症": "無法開刀之嚴重肝癌病人。",
    "劑型": "270注射劑",
    "包裝": "小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "",
    "限制項目": [
        "01國產"
    ],
    "申請商名稱": "1100905200  國立清華大學原子科學研究所同位素組",
    "申請商地址": "新竹市光復路二段１０１號",
    "主製造廠": {
        "製造廠名稱": "1100905300  國立清華大學原子科學研究所同位素組",
        "製造廠廠址": "新竹市光復路二段１０１號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30063000002 Ｘ光檢驗用不透光製劑；專供病人用之診斷用試藥Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient",
    "藥理治療分類": "",
    "ingredients": []
}